You just read:

Iroko Pharmaceuticals to Present Phase 3 VIVLODEX® Efficacy and Safety Data at World Congress of Osteoarthritis

News provided by

Iroko Pharmaceuticals, LLC

Mar 31, 2016, 08:01 ET